Baker Norton Pharmaceuticals, Inc.

Maria W Buenafe

Frank E Blondino

Michael Brucato

Kelly A Cavanaugh

Raul A Medina

Provided are pressurized metered dose inhalers containing stable formulations of a &bgr;-agonist drug in suspension or solution. Also provided are aerosol formulations suitable for inhalation therapy containing a &bgr;-agonist drug in suspension or solution.

Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant

Provided is a solution aerosol formulation adapted for use in a pressurized aerosol container. The aerosol formulation is formulated from a composition containing Budesonide, at least one fluoroalkane propellant, and a cosolvent present in an amount that dissolves or solubilizes the Budesonide in the mixture of cosolvent and propellant.

Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide

Provided is a solution aerosol formulation adapted for use in a pressurized aerosol container. The aerosol formulation is formulated from a composition containing Budesonide, Formoterol at least one fluoroalkane propellant, and a cosolvent present in an amount that dissolves or solubilizes the Budesonide and Formoterol in the mixture of cosolvent and propellant.

Growing community of inventors

Miami Beach, FL, United States of America

Maria W Buenafe